Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed method for indole ketone thioesters using sulfonyl chloride. Cost-effective supply chain solution for pharmaceutical intermediates manufacturing.
Novel palladium catalyzed carbonylation patent CN116813516B offers safe efficient synthesis of alpha beta unsaturated thioesters for pharmaceutical intermediates with reduced toxicity and cost.
Novel iron catalyzed method for cyanomethyl carboxylate synthesis offers green chemistry advantages and supply chain stability for pharmaceutical intermediate manufacturing processes.
Patent CN111423381B reveals a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply chains.
Patent CN112125856A reveals a safe palladium-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering cost-effective manufacturing solutions.
Novel Pd-catalyzed carbonylation method using benzyl formate. High yield, broad substrate scope, cost-effective for pharma intermediates.
Novel one-step synthesis of benzofuran-3-carboxamides using Pd-catalyzed carbonylation. Offers high efficiency and substrate compatibility for pharmaceutical intermediates.
Novel carbonylation route for pyrrol-2-one scaffolds offers high efficiency and substrate compatibility for pharmaceutical manufacturing.
Novel chiral phosphoric acid catalysis for high-purity anticancer intermediates. Cost-effective scale-up and reliable supply chain solutions for global pharmaceutical manufacturing partners.
Patent CN109972165B reveals a green electrochemical route for beta-trifluoromethyl amides, offering cost-effective API intermediate manufacturing without noble metal catalysts.
Novel metal-free route for trifluoromethyl triazines. Reduces cost in API manufacturing with high purity and scalability.
Novel metal-free route for trifluoromethyl 1,2,4-triazines offers cost-effective, scalable production for pharmaceutical intermediates and agrochemicals.
Patent CN111777637B discloses a novel oxindole-derived phosphine catalyst enabling mild asymmetric cyclizations with excellent yields and supply chain stability.
Patent CN103087033B reveals a catalyst-free route to oxepin-3(2H)-ones. This method offers significant cost reduction and simplified supply chains for pharmaceutical intermediate manufacturing.
Patent CN112239456B details a safe Pd-catalyzed carbonylation route for 2,3-dihydroquinolone intermediates, offering significant cost reduction in API manufacturing.
Novel Pd-catalyzed carbonylation method for 2-CF3 imidazoles offers high yield and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN115353511A details a safe, multi-component synthesis of indolinone-imidazole derivatives using in-situ CO generation, offering significant cost reduction in API manufacturing.
Patent CN109678840B reveals normal pressure hydrogenation for high-purity pomalidomide. Reduces equipment costs and enhances supply chain reliability for pharmaceutical intermediates.
Patent CN115286635A details a metal-free asymmetric synthesis of chiral pyrazolones with high ee. Offers cost-effective manufacturing for pharmaceutical intermediates.
Patent CN112920066A reveals a novel palladium-catalyzed route for alpha-amino acid esters, offering significant cost reduction in API manufacturing and reliable supply chain solutions.